{"title": "A review on scope of immuno-modulatory drugs in Ayurveda for prevention and treatment of Covid-19", "author": "Srivastava Niraj; Saxena Varsha", "url": null, "hostname": null, "description": "Publish research papers from all areas of plant science", "sitename": "Plant Science Today", "date": "2020-07-18", "cleaned_text": "A review on scope of immuno-modulatory drugs in Ayurveda for prevention and treatment disease 2019 (COVID-19) is caused by severe acute respiratory syndrome Coronavirus-2 (SARS CoV-2) infection attacking mainly on the immune system of a body. It is a potentially fatal disease that is of public health and economy concern globally. In December 2019, COVID-19 outbreak occurred in Wuhan city, Hubei Province, China furthermore spread worldwide. Research is underway in many countries to develop effective vaccines and drugs for the COVID-19. In Ayurveda, Acharya Charaka explained the concept of an epidemic condition in Janapadodhwans Adhayay and combating of these diseases is to be done by Panchakarma (five procedures of purification), Rasayana Chikitsa (good conduct). Rasayan dravyas (immuno modulators drugs) of Ayurveda can be used for health promotion, immune-modulation, prevention and reduce disease burden from COVID-19. Drugs such Ashwagandha Pippali ((Piper longum L.) For management of COVID-19 like illness Agastya Haritaki, Anutaila, AYUSH-64 can be used. Scientific research on these drugs may reveal the new approach for the prevention and management of COVID-19. The main aim of this article is to review research which has already conducted and currently being carried out on the herbal plant for their immunomodulation property which have a possible application in the prevention and treatment of COVID-19. Downloads References 2. Cucinotta D, Vanelli M. WHO Declares COVID-19 A, structure of COVID-19 spread and the lacuna in India's testing strategy. Available at SSRN 3558548. 2020. https://doi.org/10.2139/ssrn.3558548 4. Ministry of AYUSH. Ayurveda's immunity boosting measures for self care during COVID19. 2020, available from https://www.mohfw.gov.in/pdf/ImmunityBoostingAYUSHAdvisory.pdf Varanasi: Tripathi and N.P. Rai. Clinical appraisal of immunomodulators in Ayurveda in the light of recent pharmacological advances. World J. Pharm. Res. 2015; 4 (4):678-92. 7. Chauhan VP, Dutt B, Vyas M, SK. Effect of immune-modulators (Rasayana Dravya) in Janapadodhwansa WSR to 29. 8. Kumar VP, Kuttan R, Kuttan G. Effect of ''Rasayanas'' a herbal drug preparation on cell mediated immune responses in tumor bearing mice. Indian J Exp. Biol. Charaka & no.3, page no. 252. 11. Tripathi JS, Singh RH. The concept and practice of immunomodulation in Ayurveda and the role of Rasayanas as immunomodulators. Ancient Science of Life. 1999; 19(1-2):59. 12. Nikhat S, Fazil M. Overview of COVID-19; its prevention and management in the light of Unani medicine. Science of the total Environment. 2020. Vol 728:138859. https://doi.org/10.1016/j.scitotenv.2020.138859 13. Yang H, Bartlam M, Rao Z. Drug design targeting the main protease, the Achilles' heel of coronaviruses. Current pharmaceutical design. 2006; 12(35):4573-90. https://doi.org/10.2174/138161206779010369 14. Zhang H, JM, AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive care medicine. 2020; 46(4):586-90. https://doi.org/10.1007/s00134-020-05985-9 15. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan COVID-19. BioRxiv 2020.01.26.919985. https://doi.org/10.1101/2020.01.26.919985 16. Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res. 2020; 7(1):11. https://doi.org/10.1186/s40779-020-00240-0 17. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet.2020; 395(10223):497-506.https://doi.org/10.1016/S0140-6736(20)30183-5. 18. Tang YW, JE, Persing DH, Stratton CW. Laboratory diagnosis of COVID-19: current issues and challenges. Journal of clinical microbiology. 2020; 58(6); 12-20. https://doi.org/10.1128/JCM.00512-20 19. Padhi A, Kumar S, Gupta E, Saxena SK. Laboratory Diagnosis of Novel Coronavirus Disease 2019 (COVID-19) Infection. In Coronavirus Disease 2019 (COVID-19) 2020 (pp. 95-107). Springer, Singapore. https://doi.org/10.1007/978-981-15-4814-7_9 20. Tsang OT, Chau TN, Choi KW, Tso EY, Lim W, Chiu MC, et al. Severe acute respiratory syndrome: relapse? Hospital infection? infectious A, Gairola S, et al. rasayana prophylaxis COVID-19. Curr Sci. 2020; 118:1158-60. 22. Kindler E, Thiel V, Weber F. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. Adv Virus Res. 2016; Vol. 96: 219-243. https://doi.org/10.1016/bs.aivir.2016.08.006 23. Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clinical & Immunology. et al. TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy. Roum Arch Microbiol Immunol. 2010;69(1):24-34 25. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, Liu C, Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020; 87: 18-22. https://doi.org/10.1016/j.bbi.2020.03.031 26. Jean SS, Lee PI, Hsueh PR. Treatment options for COVID-19: The reality and challenges. J. Microbiol. 436-443. https://doi.org/10.1016/j.jmii.2020.03.034 Herbal plants as new immuno-stimulator in poultry industry: a review. Asian Journal of Animal and Veterinary Advances. 2012; 7(2):105-16. https://doi.org/10.3923/ajava.2012.105.116. Hari Abdul Samad, et al. Immunomodulatory and Therapeutic Potentials of Herbal, Traditional/Indigenous and Ethnoveterinary Medicines. Pakistan Journal of Biological Sciences. 2012; https://doi.org/10.3923/pjbs.2012.754.774 29. Tiwari (Withania somnifera): Role in safeguarding health, immunomodulatory effects, combating infections and therapeutic applications: A review. Journal of Biological Sciences. 2014; 14 (2):77-94. SS, BK. Immune response to DPT vaccine by aqueous extract of Withania somnifera in experimental system. International immunopharmacology. 4 31. Kumar R, Rai J, Kajal NC, Devi P. Comparative study of effect of Withania somnifera as an adjuvant to DOTS in patients of newly diagnosed sputum smear positive pulmonary tuberculosis. Indian Journal of Tuberculosis. 2018; 65 (3):246-51. https://doi.org/10.1016/j.ijtb.2017.05.005. 32. Akhtar S. Use of Tinospora Indian of 33. Upadhyaya R, Pandey RP, Verma Anita K. Assessment of the multifaceted immunomodulatory potential of the aqueous extract of Tinospora cordifolia. Research Journal of Chemical Sciences. 1(6): 71-79. 34. Mainzen Prince PS, Padmanabhan by ethanolic Tinospora cordifolia extract in alloxan?induced diabetic liver and kidney. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 2004; 18 https://doi.org/10.1002/ptr.1567 35. Aranha I, Clement F, Venkatesh YP. Immunostimulatory properties of the major protein from the stem of the Ayurvedic medicinal herb, guduchi (Tinospora cordifolia). Journal (2):366-72. Ministry of AYUSH, Advisory from ministry of Ayush for meeting the challenge arising out of spread of corona virus (COVID-19) in India. 2020. available from: https://www.ayush.gov.in/docs/125.pdf. 25 verse 40. Varanasi: Chaukumba Sanskrit Sansthan; Varanasi: Sanskrit https://doi.org/10.3390/biom9050161. 40. of Emblica officinalis against Klebsiella pneumoniae induced pneumonia in mice. Indian Journal of Medical Research. 2008; 128 (2):188-93. 41. Tsuchiya H, Sato M, Miyazaki T, Fujiwara S, Tanigaki S, Ohyama M, Tanaka T, Iinuma M. Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus Repine ID, Oxidative Stress Study Group. Oxidative stress in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 1997; 156 (2):341-57. https://doi.org/10.1164/ajrccm.156.2.9611013. 43. Cinatl J, H, Doerr HW. Glycyrrhizin, an active component of liquorice SARS-associated coronavirus. The Lancet. 2003; 361 (9374):2045-6. https://doi.org/10.1016/S0140-6736(03)13615-X. 44. Wang L, Yang R, Yuan B, Liu Y, Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. 45. Akamatsu Komura J, Asada Y, Niwa Y. Mechanism of anti-inflammatory action of glycyrrhizin: effect on neutrophil functions https://doi.org/10.1055/s-2006-960045 Mose PB, Karandikar SM. Protective effect of Asparagus racemosus against induced abdominal sepsis. Indian Drugs. 1986; 24(3):125-8. 47. Gautam M, Diwanay B. Immunoadjuvant potential of Asparagus racemosus aqueous extract in experimental system. Journal of ethnopharmacology. 2004; 91 (2-3):251-5. https://doi.org/10.1016/j.jep.2003.12.023 48. Naik SR, Hule A. Evaluation of immunomodulatory an of Nahata MC. Complementary and alternative medicine for upper-respiratory-tract infection in children. American journal of health-system pharmacy. 2006; 63(1):33-9. https://doi.org/10.2146/ajhp040613 50. Cohen MM. Tulsi-Ocimum sanctum: A herb for all reasons. Journal of Ayurveda and integrative medicine. 2014; 5 (4):251-59. https://doi.org/10.4103/0975-9476.146554. 51. Pattanayak Das D, Panda SK. Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An Pharmacognosy reviews. 2010; immunomodulatory effects of Tulsi (Ocimum sanctum Linn.) leaf extract on healthy volunteers. Journal 2011; 136 (3):452-6. https://doi.org/10.1016/j.jep.2011.05.012. 53. Ravi A, Chandramuki A, Gourie?Devi M, Grau GE. Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. Journal of medical virology. 1997; 51(2):132-6. https://doi.org/10.1002/(SICI)1096-9071(199702)51:2<132::AID-JMV8>3.0.CO;2-8. 54. Sangeetha P, Poornamathy JJ. anti-inflammatory activity of Ocimum (karunthulasi of Boerhaavia diffusa alkaloid Asian Agri-History. 2006; 10 (1):55-68. 58. Sunila P, Carol M, Mayuree P. Phytochemical and therapeutic potential of Piper longum Linn a review. International journal of research in Ayurveda and pharmacy. 2011; 2 (1):157-61. 60. Jyothy KB, Sheshagiri S, Patel KS, Rajagopala S. A critical appraisal on Swarnaprashana in children. Ayu. 2014; 35(4):361. https://doi.org/10.4103/0974-8520.158978. 61. Kumar SN. Swarnaprashana to Swarnamritaprashana: experience inspired modification through ages. International journal of pharmaceutical sciences and research. 2017; 8 (11):4546-50. 62. Bajaj S, Ahmad I, Raisuddin S, Vohora SB. Augmentation of non-specific immunity in mice by gold preparations used in traditional systems of medicine. Indian J Med Res Indian. 2001; 113:192-96. 63. Ministry of Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), Government of India, 2020, available from: https://health.ncog.gov.in/ayush-covid-dashbaord 64. Central Council for Research in Ayurvedic Sciences (CCRAS), 2014, available Astang (2011), p. 293-94. Downloads Published How to Cite Issue Section License Copyright (c) 2020 Srivastava Niraj, Saxena Varsha This work is licensed under Commons Attribution 4.0 International License](https://creativecommons.org/licenses/by/4.0/). Copyright and Licence details of published articles Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a [Creative Commons Attribution License](http://creativecommons.org/licenses/by/3.0/)that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Open Access Policy Plant Science Today is an open access journal. There is no registration required to read any article. All published articles are distributed under the terms of the Creative Commons Attribution License (CC Attribution 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited ( [https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See [The Effect "}